
Alignment Healthcare (ALHC) Stock Forecast & Price Target
Alignment Healthcare (ALHC) Analyst Ratings
Bulls say
Alignment Healthcare Inc is strategically positioned to capitalize on the stronger Medicare Advantage (MA) rate update in 2026, particularly as several managed care organizations (MCOs) are reducing their benefits, while Alignment benefits from a Stars funding advantage. The company’s integrated Medicare Advantage-Value-Based Care (MA-VBC) model is expected to support long-term market share gains and foster above-average growth prospects. Moreover, projected gross profit per member per month (PMPM) for the initial cohorts ranges from $90 to $150, with potential progression to over $230 PMPM in later years, indicating robust financial efficiency and growth potential.
Bears say
The financial analysis of Alignment Healthcare, Inc. reveals a concerning outlook primarily due to challenges linked to its value-based care model, which is hindered by data friction among various payors and difficulties in achieving consistent clinical outcomes. Although the company demonstrates a lower average daily cost per member (ADK) amidst increased healthcare utilization, this may not translate into sustainable financial performance as market dynamics shift. Furthermore, despite reporting above-average EBITDA growth and operating against public targets, the elevated valuation multiples compared to peer managed care organizations highlight a potential overvaluation, suggesting that investor expectations may not be aligned with underlying operational risks.
This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Alignment Healthcare (ALHC) Analyst Forecast & Price Prediction
Start investing in Alignment Healthcare (ALHC)
Order type
Buy in
Order amount
Est. shares
0 shares